Announcements
Sidley Represents D1 Capital in Imperative Care US$150 Million Series E Financing
August 7, 2024
Sidley represented D1 Capital Partners as an investor in the US$150 million Series E financing round of Imperative Care, a commercial-stage medical technology company researching and developing connected innovations to elevate care for people affected by vascular diseases such as stroke and pulmonary embolism. Also participating in the round were other existing investors including Ally Bridge Group, AMED Ventures, Bain Capital Life Sciences, Innovatus Capital Partners, LLC, Pura Vida Investments, and Rock Springs Capital Management LP.
The Sidley team was led by Geoffrey W. Levin (M&A and Private Equity) and included Chris Crane (M&A and Private Equity), Jamie M. Sadler (Antitrust and Competition), Katie Klaben (Capital Markets), and Ching-Lee Fukuda and Sharon Lee (IP Litigation).
The Sidley team was led by Geoffrey W. Levin (M&A and Private Equity) and included Chris Crane (M&A and Private Equity), Jamie M. Sadler (Antitrust and Competition), Katie Klaben (Capital Markets), and Ching-Lee Fukuda and Sharon Lee (IP Litigation).
Contacts
Capabilities
Suggested News & Insights
Drinks With The Deal: Sidley’s Mehdi KhodadadApril 17, 2026Sidley Represents Orion Resource Partners in Combination of Sweetwater Royalties With Uranium RoyaltyApril 16, 2026FactSet Ranks Sidley No. 1 for Company Defense in Q1 2026April 15, 2026Delaware Supreme Court Reinforces the Importance of Precision in Drafting ADR Provisions in Merger AgreementsApril 14, 2026Sidley Represents AIP in Its US$1.272 Billion Acquisition of Avanos MedicalApril 14, 2026Sidley Secures Several Top 10 M&A and Private Equity League Tables ResultsApril 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory